What is a drug reimbursement?

drug reimbursement indicates a situation where the drug company is paid by a third party for the whole or part of the regulation, or where the third party pays the consumer part or all the price of the regulation. Different insurance companies can handle this process in different ways and in some cases it may depend on the drug manufacturer. Drug reimbursement is often an advantage of health insurance plan, although not all plans offer prescription drugs.

In cases where the drug manufacturer is returned, the consumer is responsible for doing very little differently than going to the place and picking up the medicine. Depending on the plan, the consumer may have to offer some money on the costs of a prescription as a deductible. The pharmacy then processes the rest of the transaction by reversing to an insurance company that records the drug of selection, regulation, completed date and other relevant information. This can be done either in a paper sub -network through the electronic network.

For plans for reimbursement of drugs relying on the patient in order to manage this claim, the patient must generally pay the entire regulation costs in advance. This can create at least temporary problems for the patient until the money is returned. Insurance companies can often be a method to stimulate the patient to take a general drug that will create less temporary expenses for the patient and insurance company. The turnover for drug reimbursement may vary with each company and a number of processed demands.

Regardless of which method is used, it is a general trend of drug reimbursement strategy to promote the use of multiple generics. This can significantly reduce the costs of insurance companies. For example, in the second quarter of 2009, the average price of a drug brand was approximately $ 14 US dollars (USD). The general equivalent costs an average of $ 20.48. In addition to the strategy of getting the patient to pay for the cost in advance, some pharmaceutical companies support the use of generics only by paying MALou part of the brand name tag, if there is a generic, compared to paying for all or almost all general.

Not all drug reimbursement companies will make all drugs available as planned. For example, some drugs may be considered to be an improvement in the quality of life and are therefore optional and are not subject to payment. Some insurance providers may also have relationships with some drug manufacturers and have exclusive benefits with these manufacturers. Moreover, newer medicines must usually undergo the evaluation process before they are issued. Those who are not sure what their medicine is offering their plan to check for their insurance companies before completing the regulation.